The global lab robotics demand reached over US$ 186 Million in 2022 and is forecast to grow at a robust CAGR of around 6.8% between 2022 and 2032, totaling approximately US$ 300 Million by 2032. Growth is attributable to the growing popularity of robotics technology and rising integration of automation across pharmaceutical and biopharmaceutical industries, research laboratories, and clinical laboratories.
| Report Attribute | Details |
| Lab Robotics Market Expected Market Value (2022) | US$ 186 Million |
| Lab Robotics Market Anticipated Forecast Value (2032) | US$ 300 Million |
| Lab Robotics Market Projected Growth Rate (2022-2032) | 6.8% CAGR |
Rapid penetration of automation has given a significant boon to the growth of lab robotics market during the last few years and the trend is likely to continue during the forecast period.
Lab robotics refers to the use of robots for performing or assisting several laboratory tasks across various end user verticals including pharmaceutical industry, research laboratories, and clinical laboratories. Adoption of robotics technology has effectively optimized laboratory processes and minimized even the slightest errors by reducing human intervention.
Most of the pharmaceutical companies and research laboratories in the contemporary world are showing a keen inclination towards adopting robotics technology in their facilities due to its various benefits including increased productivity, safe working conditions, consistent results, faster speed, and cost savings.
Many tasks which are mundane and repetitive may be tedious to carry out for humans and thus there is a high chance of errors in the results. In order to minimize these errors and increase productivity, end users employ robots. This is acting as a catalyst for the growth of lab robotics market.
The life science industry segment is expected to accrue significant benefits to the global lab robotics market during the forecast period, owing to the rapid adoption of robots for performing a multitude of functions. Various studies have concluded that up to 80% of tasks in life science industry can benefit vastly by using lab robotics.
Similarly, advancements in robotics coupled with growing penetration of lab automations across emerging nations such as Asia Pacific and MEA will further expand the size of lab robotics market during the forthcoming years.
Rising expenditure by pharmaceutical companies on research and development, technological advancements in robotics technology, increasing penetration of automation, surge in the number of end use verticals, and increasing adoption of lab robotics for optimizing laboratory processes and reducing overall costs as well as time are some of the major factors driving the global lab robotics market.
Over the last few years, use of robots across various end use verticals such as pharmaceutical industry, research laboratories, life science industry etc. has significantly increased at an incredible pace. They have gained immense traction on account of their ability to perform even the most tedious work at faster speeds and with accurate results. Besides this, they significantly reduce human involvement and minimize the overall production costs.
The high productivity of robots in performing laboratory tasks with minimal wastage is expected to boost the growth of lab robotics during the assessment period.
Similarly, rising concerns regarding the safety of workers coupled with presence of stringent regulatory protocols in laboratories will continue to encourage the end users for adopting robotics technology for critical process applications during the assessment period.
Leading manufacturers are continuously introducing various small and lightweight laboratory robots with suitable designs and affordable prices which can be deployed for several operations in limited space. This will help them to increase sales and expand their customer base during the forecast period.
Additionally, rising prevalence of chronic diseases along with increasing investments in drug research and development activities, and growing concerns regarding the spread of infections across clinical laboratories is expected to support the market growth in the future.
Despite the growing popularity of lab robotics, there are numerous obstacles likely to pose a challenge to market growth. Some of these factors are the high initial cost of installation, lack of appropriate guidelines for using lab robotics, less flexibility when tasks are switched, and poor penetration of lab robotics across various developing and underdeveloped regions of the world.
According to Future Market Insights, North America is expected to remain the undisputed world leader in the lab robotics market during the forecast period, owing to the easy availability of robotics solutions, presence of well-trained professionals to handle the lab robotics, increasing adoption of automation by clinical and research laboratories, and large base of robotics manufacturing companies across countries like the United States.
Demand for lab robotics is especially high across the United States due to increasing research and development activities by pharmaceutical and biopharmaceutical firms, rising concerns about the safety of workers in clinical laboratories, and presence of stringent regulations.
Rapid automation across industries is another key factor that is fueling the adoption of robotics in North American countries and the trend is likely to prevail during the assessment period.
With rapid rise in the number of end use verticals and the heavy presence of robotics manufacturing giants, Europe is slated to emerge as the second most lucrative market for lab robotics during the forecast period from 2022 to 2032.
Most of the pharmaceutical companies and clinical laboratories in countries like the United Kingdom, Germany, and France are employing robotics in drug development processes, research and disease diagnostic procedures to enhance productivity, minimize human interference, and reduce costs.
Increasing number of end users coupled with rising investments in R&D by pharmaceutical and biopharmaceutical companies is expected to generate lucrative growth prospects within the Europe lab robotics market during the forecast period.
Some of the key participants present in the global lab robotics market include AB Controls, Thermo Fisher Scientific, Aurora Biomed, Tecan Group, Peak Analysis & Automation, Yaskawa Electric, Chemspeed Technologies, ALS Automated Lab Solutions, Hudson Robotics, Universal Robots, and ST Robotics.
These leading players are continuously innovating for developing advanced products that not only optimize laboratory processes but also eliminate the chances of errors. Besides this they are adopting various organic and inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations to penetrate emerging markets.
| Report Attribute | Details |
| Growth Rate | CAGR of 6.8% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By End User:
By Region:
As per FMI, the global lab robotics market is anticipated to grow at a healthy CAGR of around 6.8% during the forecast period from 2022 to 2032.
North America is expected to remain the most lucrative market for lab robotics during the forecast period.
AB Controls, Thermo Fisher Scientific, Aurora Biomed, Tecan Group, Peak Analysis & Automation, Yaskawa Electric, and Chemspeed Technologies are some prominent lab robotics market players.
Explore Similar Insights
Lab Robotics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
